|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.265 HKD | +3.92% |
|
+1.92% | +21.56% |
Tianda Pharmaceuticals Limited reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was HKD 410.02 million. Net loss was HKD 40.98 million.
Basic loss per share from continuing operations was HKD 0.0191.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.56% | 72.78M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
TIANDA PHARMACEUTICALS LIMITED 
